Prolonged exposure to resistin inhibits glucose uptake in rat skeletal muscles

Acta Pharmacologica Sinica

Volumn 28, Issue 3, 2007, Pages 410-416

  Fan, Hong Qi ^a   Gu, Nan ^a   Liu, Feng ^a   Fei, Li ^a   Pan, Xiao Qin ^a   Guo, Mei ^a   Chen, Rong Hua ^a   Guo, Xi Rong ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Diabetes; Glucose uptake; Insulin; Obesity; Resistin

Indexed keywords

DEOXYGLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR SUBSTRATE 1; RESISTIN; SYNAPTOSOMAL ASSOCIATED PROTEIN 23;

ANIMAL CELL; ANIMAL CELL CULTURE; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG EXPOSURE; DRUG INHIBITION; DRUG MECHANISM; GENETIC TRANSFECTION; GLUCOSE TRANSPORT; LIQUID SCINTILLATION COUNTING; MYOBLAST; MYOTUBE; NONHUMAN; PROTEIN CONTENT; PROTEIN PHOSPHORYLATION; RAT; SKELETAL MUSCLE; SUPERNATANT; T LYMPHOCYTE; WESTERN BLOTTING;

ANIMALS; ANTIMETABOLITES; CELL DIFFERENTIATION; CELLS, CULTURED; DEOXYGLUCOSE; GLUCOSE; HYPOGLYCEMIC AGENTS; INSULIN; MUSCLE FIBERS, SKELETAL; MUSCLE, SKELETAL; MYOBLASTS; PLASMIDS; RATS; RESISTIN; TRANSFECTION;

EID: 33847195777     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2007.00523.x     Document Type: Article

References (26)

1. Steppan CM, Bailey ST, Bhat S, Briwn EJ, Baberjee RR, Wright CM, et al. The hormone resistin links obesity to diabetes. Nature 2001; 409: 307-12.
2. Rajala MW, Lin Y, Ranalletta M, Yanq XM, Qian H, Ginqerich R, et al. Cell type-specific expression and coregulation of murine resistin and resistin-like molecule-alpha in adipose tissue. Mol Endocrinol 2002; 16: 1920-30.
3. Steppan CM, Lazar MA. Resistin and obesity-associated insulin resistance. Trends Endocrinol Metab 2002; 13: 18-23.
4. Rajala MW, Qi Y, Patel HR, Takahashi N, Baberjee R, Pajvani UB, et al. Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting. Diabetes 2004; 53: 1671-9.
5. Ghosh S, Singh AK, Aruna B, Mukhopadhyay S, Ehtesham NZ. The genomic organization of mouse resistin reveals major differences from the human resistin: functional implications. Gene 2003; 305: 27-34.
6. Lehrke M, Reilly MP, Millington SC, Iqbal N, Rader DJ, Lazar MA. An inflammatory cascade leading to hyperresistinemia in humans. Plos Med 2004; 1: e45.
7. Degawa-Yamauchi M, Bovenkerk JE, Juliar BE, Watson W, Kerrk K, Jones R, et al. Serum resistin (FIZZ3) protein is increased in obese humans. J Clin Endocrinol Metab 2003; 88: 5452-5.
8. McTernan PG, Fisher FM, Valsamakis G, Chetty R, Harte A, McTernan CL, et al. Resistin and type 2 diabetes: regulation of resistin expression by insulin and rosiglitazone and the effects of recombinant resistin on lipid glucose metabolism in human differentiated adipocytes. J Clin Endocrinol Metab 2003; 88: 6098-106.
9. Bajaj M, Suraamornkul S, Hardies LJ, Pratipanaeatr T, DeFronzo RA. Plasma resistin concentration, hepatic fat content, and hepatic and peripheral insulin resistance in pioglitazone-treated type II diabetic patients. Int J Obes Relat Metab Disord 2004; 28: 783-9.
10. McTernan PG, Kusminski CM, Kumar S. Resistin. Curr Opin Lipidol 2006; 17: 170-5.
11. Gong H, Ni Y, Guo X, Fei L, Pan X, Guo M, et al. Resistin promotes 3T3-L1 preadipocyte differentiation. Eur J Endocrinol 2004; 150: 885-92.
12. el-Naqqar, Kanda F, Okuda S, Maeda N, Nishimoto K, Ishihara H, et al. Direct effects of tumor necrosis factor alpha (TNF-alpha) on L6 myotubes. Kobe J Med Sci 2004; 50: 39-46.
13. Ceddia RB, Somwar R, Maida A, Fanq X, Bikopouls G, Sweeney G. Globular adiponectin increases GLUT4 translocation and glucose uptake but reduces glycogen synthesis in rat skeletal muscle cells. Diabetoloqia 2005; 48: 132-9.
14. Andreozzi F, Laratta E, Sciacqua A, Perticone F, Sesti G. Angiotensin II impairs the insulin signaling pathway promoting production of nitric oxide by inducing phosphorylation of insulin receptor substrate-1 on Ser312 and Ser616 in human umbilical vein endothelial cells. Circ Res 2004; 94: 1211-8.
15. Banerjee RR, Rangwala SM, Shapiro JS, Rich AS, Rhoades B, Qi Y, et al. Regulation of fasted blood glucose by resistin. Science 2004; 303: 1195-8.
16. Pravenec M, Kazdova L, Landa V, Zidek V, Mlejnek P, Jansa P, et al. Transgenic and recombinant resistin impair skeletal muscle glucose metabolism in the spontaneously hypertensive rat. J Biol Chem 2003; 278: 45 209-15.
17. Kim KH, Zhao L, Moon Y, Kang C, Sul HS. Dominant inhibitory adipocyte-specific secretory factor (ADSF)/resistin enhances adipogenesis and improves insulin sensitivity. Proc Natl Acad Sci USA 2004; 101: 6780-5.
18. Muse ED, Obici S, Bhanot S, Monia BP, McKay RA, Rajala MW, et al. Role of resistin in diet-induced hepatic insulin resistance. J Clin Invest 2004; 114: 232-9.
19. Satoh H, Nguyen MT, Miles PD, Imamura T, Usui I, Olefsky JM. Adenovirus-mediated chronic "hyper-resistinemia" leads to in vivo insulin resistance in normal rats. J Clin Invest 2004; 114: 224-31.
20. Moon B, Kwan JJ, Duddy N, Sweeney G, Begum N. Resistin inhibits glucose uptake in L6 cells independently of changes in insulin signaling and GLUT4 translocation. Am J physiol Endocrinol Metab 2003; 285: E106-15.
21. Giovannone B, Scaldaferri ML, Federici M, Porzio O, Lauro D, Fusco A, et al. Insulin receptor substrate (IRS) transduction system: distinct and overlapping signaling potential. Diabetes Metab Res Rev 2000; 16: 434-41.
22. Sowers JR. Insulin resistance and hypertension, Am J Physiol Heart Circ Physiol 2004; 286: 1597-602.
23. Taniquchi CM, Emanuelli B, Kahn CR. Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol 2006; 7: 85-96.
24. Gual P, Le Marchand-Brustel Y, Tanti JF. Positive and negative regulation of insulin signaling through IRS-1 phosphorylation. Biochimie 2005; 87: 99-109.
25. Bryant NJ, Govers R, James DE. Regulated transport of the glucose transporter GLUT4. Nat Rev Mol Cell Biol 2002; 3: 267-77.
26. Foster LJ, Klip A. Mechanism and regulation of GLUT-4 vesicle fusion in muscle and fat cells. Am J Physiol Cell Physiol 2000; 279: C877-90.